Bg pattern

BRONCHIPRET FILM-COATED TABLETS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use BRONCHIPRET FILM-COATED TABLETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show translation

Introducción

Prospecto: información para el paciente

Bronchipret comprimidos recubiertos con película

Extracto seco de Prímula

Extracto seco de Tomillo

Lea todo el prospecto detenidamente antes de empezar a tomar este medicamento, porque contiene información importante para usted.

Siga exactamente las instrucciones de administración del medicamento contenidas en este prospecto o las indicadas por su médico o farmacéutico.

  • Conserve este prospecto, ya que puede tener que volver a leerlo.
  • Si necesita consejo o más información, consulte a su farmacéutico.
  • Si experimenta efectos adversos, consulte a su médico o farmacéutico, incluso si se trata de efectos adversos que no aparecen en este prospecto. Ver sección 4.
  • Debe consultar a un médico si empeora o si no mejora después de 1 semana.

Contenido del prospecto

  1. Qué es Bronchipret y para qué se utiliza
  2. Qué necesita saber antes de empezar a tomar Bronchipret
  3. Cómo tomar Bronchipret
  4. Posibles efectos adversos
  5. Conservación de Bronchipret
  6. Contenido del envase e información adicional

1. Qué es Bronchipret y para qué se utiliza

Bronchipret es un medicamento a base de plantas que se utiliza en caso de tos productiva para facilitar la expectoración de flemas.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. Qué necesita saber antes de empezar a tomar Bronchipret

No tome Bronchipret:

  • si es alérgico a los principios activos, a otras plantas de la familia Lamiaceae o a alguno de los demás componentes de este medicamento (incluidos en la sección 6).

Advertencias y precauciones

Consulte a su médico o farmacéutico antes de empezar a tomar Bronchipret:

  • si tiene la respiración entrecortada, fiebre o esputo purulento;
  • si padece gastritis o úlcera gástrica;
  • si empeoran los síntomas durante el uso del medicamento.

Niñosy adolescentes

No se ha establecido todavía el uso en niños y adolescentes de menos de 18 años debido a la falta de datos adecuados sobre su eficacia.

Toma deBronchipretconotros medicamentos

No se han realizado estudios de interacciones clínicas.

Informe a su médico o farmacéutico si está tomando, ha tomado recientemente o pudiera tener que tomar cualquier otro medicamento.

Embarazo y lactancia

No se ha establecido la seguridad durante el embarazo.

A falta de datos suficientes, no se recomienda el uso durante el embarazo.

Se desconoce si los principios activos o los metabolitos de Bronchipret se excretan con la leche materna. Por lo tanto, no se debe utilizar Bronchipret durante el periodo de lactancia.

Si está embarazada o en periodo de lactancia, cree que podría estar embarazada o tiene intención de quedarse embarazada, consulte a su médico o farmacéutico antes de utilizar este medicamento.

Conducción y uso de máquinas

No se han realizado estudios acerca de la capacidad de conducción y uso de maquinaria.

Bronchipret contiene glucosa y lactosa

Si su médico le ha dicho que tiene intolerancia a algunos azúcares, póngase en contacto con él antes de tomar este medicamento.

Bronchipret contiene sodio.

Este medicamento contiene menos de 1 mmol de sodio (23 mg) por comprimido; esto es, esencialmente “exento de sodio”.

3. Cómo tomar Bronchipret

Siga exactamente las instrucciones de administración de este medicamento contenidas en este prospecto o las indicadas por su médico o farmacéutico. En caso de duda, consulte de nuevo a su médico o farmacéutico.

La dosis recomendada es:

Adultos: 1 comprimido 3 veces al día (máximo, 3 comprimidos diarios).

Tome Bronchipret sin masticar antes de las comidas y con líquido suficiente (preferentemente, un vaso de agua).

Si los síntomas persisten más de 1 semana durante el uso del medicamento, se debería consultar a un médico o a un profesional sanitario cualificado.

No se dispone de datos suficientes para recomendaciones de posología en pacientes con una función renal o hepática disminuida.

Uso en niños y adolescentes

No se recomienda el uso en niños y adolescentes de menos de 18 años (ver la sección 2).

Si toma más Bronchipret del que debe

No se ha notificado ningún caso de sobredosis.

Una sobredosis podría provocar malestar, vómitos o diarrea.

Informe a su médico si ha tomado más Bronchipret del que debe. Su médico decidirá las medidas necesarias.

Si olvidó tomar Bronchipret

No tome una dosis doble para compensar la dosis olvidada, pero continúe tomando Bronchipret tal y como lo prescribió su médico o como se describe en este prospecto.

Si interrumpe el tratamiento con Bronchipret

Por lo general, interrumpir el tratamiento con Bronchipret es inofensivo.

Si tiene cualquier otra duda sobre el uso de este medicamento, pregunte a su médico o farmacéutico.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Posibles efectos adversos

Al igual que todos los medicamentos, este medicamento puede producir efectos adversos, aunque no todas las personas los sufran.

Efectos adversos poco frecuentes (pueden afectar hasta a 1 de cada 100 personas):

Trastornos gastrointestinales, como calambres, náuseas, vómitos y diarrea.

Efectos adversos muy raros (pueden afectar hasta a 1 de cada 10.000 personas)

Reacciones de hipersensibilidad, como respiración entrecortada, erupciones, urticaria e hinchazón de la cara, boca o garganta.

En el caso de observar los primeros síntomas de reacción de hipersensibilidad, no se debe volver a tomar Bronchipret.

Comunicación de efectos adversos

Si experimenta cualquier tipo de efecto adverso, consulte a su médico o farmacéutico, incluso si se trata de posibles efectos adversos que no aparecen en este prospecto. También puede comunicarlos directamente a través del Sistema Español de Farmacovigilancia de Medicamentos de Uso Humano: www.notificaRAM.es. Mediante la comunicación de efectos adversos usted puede contribuir a proporcionar más información sobre la seguridad de este medicamento.

5. Conservación de Bronchipret

No conservar a temperatura superior a 25ºC.

Conservar los blísters en el envase original para proteger de la luz y de la humedad.

Mantener este medicamento fuera de la vista y del alcance de los niños.

No utilice este medicamento después de la fecha de caducidad que aparece en el envase después de CAD. La fecha de caducidad es el último día del mes que se indica.

Los medicamentos no se deben tirar por los desagües ni a la basura. Deposite los envases y los medicamentos que no necesita en el Punto SIGRE de la farmacia. Pregunte a su farmacéutico cómo deshacerse de los envases y de los medicamentos que ya no necesita. De esta forma, ayudará a proteger el medio ambiente.

6. Contenido del envase en información adicional

Composición de Brochipret

  • Los principios activos son 60 mg de extracto (como extracto seco) de Primula veris L./Primula elatior (L.) Hill, radix (raíz de Prímula) (6 - 7: 1). Solvente de extracción: Etanol 47,4% (V/V).

160 mg de extracto (como extracto seco) de Thymus vulgarisL./Thymus zygisL., herba (tomillo) (6 - 10: 1). Solvente de extracción: Etanol 70% (V/V).

  • Los demás componentes son: celulosa microcristalina, lactosa monohidrato, glucosa líquida deshidratada por atomización, sílice coloidal anhidro, dispersión de poliacrilato al 30%, crospovidona, hipromelosa, talco, povidona K 25, estearato de magnesio, dióxido de titanio (E171), propilenglicol, sabor a menta (contiene goma arábiga, maltodrextina, lactosa), clorofilina cúprica E141 (contiene jarabe de glucosa), sacarina sódica, simeticona, dimeticona, riboflavina (E101).

Aspecto del producto y contenido del envase

Los comprimidos recubiertos con película son verdes, redondos y biconvexos y tienen una superficie semiopaca. El comprimido recubierto con película tiene un diámetro de 10,1 a 10,3 mm.

Bronchipret se presenta en blísters de PVC/PVDC/ aluminio.

Está disponible en los tamaños de envase siguientes:

20 comprimidos

50 comprimidos

100 comprimidos

Puede que solamente se comercialicen algunos tamaños de envases.

Titular de la autorización de comercialización y responsable de la fabricación

BIONORICA SE

Kerschensteinerstraße 11-15

92318 Neumarkt

Alemania

Tel.: +49 (0)9181 231-90

Fax: +49 (0)9181 231-265

E-mail: [email protected]

Este medicamento está autorizado en los estados miembros del EEE con los nombres siguientes:

Austria, Bulgaria, Croacia, Alemania, Luxemburgo, Países Bajos, Noruega, Eslovenia,

Bronchipret TP

Estonia, Finlandia, Francia, Letonia, Dinamarca, Lituania, Suecia

Mucopret

Polonia

Bronchitabs

Rumanía

Mucopret comprimate filmate

España

Bronchipret comprimidos recubiertos con película

Eslovaquia

Mucopret filmom obalené tablety

Fecha de la última revisión de este prospecto: Octubre 2022

La información detallada y actualizada de este medicamento está disponible en la página web de la Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) (http://www.aemps.gob.es/)

Online doctors for BRONCHIPRET FILM-COATED TABLETS

Discuss questions about BRONCHIPRET FILM-COATED TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (32)
Doctor

Dmytro Horobets

Family medicine 7 years exp.

Dr. Dmytro Horobets is a licensed family medicine physician in Poland, specialising in endocrinology, diabetology, obesity management, gastroenterology, pediatrics, general surgery, and pain medicine. He offers online consultations for adults and children, providing personalised medical support for a wide range of acute and chronic health concerns.

Areas of expertise:

  • Endocrinology: diabetes type 1 and type 2, prediabetes, thyroid disorders, metabolic syndrome, hormonal imbalance.
  • Obesity medicine: structured weight management plans, nutritional counselling, obesity-related health risks.
  • Gastroenterology: acid reflux (GERD), gastritis, irritable bowel syndrome (IBS), liver and biliary conditions.
  • Pediatric care: infections, respiratory symptoms, digestive issues, growth and development monitoring.
  • General surgery support: pre- and post-surgical consultations, wound care, rehabilitation.
  • Pain management: chronic and acute pain, back pain, joint pain, post-traumatic pain syndromes.
  • Cardiovascular health: hypertension, cholesterol control, risk assessment for heart disease.
  • Preventive medicine: regular check-ups, health screenings, long-term management of chronic conditions.

Dr. Horobets combines evidence-based medicine with a patient-centred approach. He carefully evaluates each patient’s medical history and symptoms, offering clear explanations and structured treatment plans adapted to individual needs.

Whether you need help managing diabetes, tackling weight-related health issues, interpreting lab results, or receiving general family medicine support, Dr. Horobets provides professional online care tailored to your specific health goals.

Camera Book a video appointment
€60
5.0 (4)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques. For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance. Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults. In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions. Patients commonly seek his care for: 

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns

Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.

Camera Book a video appointment
€80
5.0 (34)
Doctor

Anna Biriukova

General medicine 6 years exp.

Dr Anna Biriukova is an internal medicine doctor with clinical experience in cardiology, endocrinology, and gastroenterology. She provides online consultations for adults, offering expert medical support for heart health, hormonal balance, digestive issues, and general internal medicine.

Cardiology – Diagnosis and treatment of:

  • High blood pressure, blood pressure fluctuations, and cardiovascular risk prevention.
  • Chest pain, shortness of breath, arrhythmias (tachycardia, bradycardia, palpitations).
  • Leg swelling, chronic fatigue, reduced exercise tolerance.
  • EKG interpretation, lipid profile evaluation, cardiovascular risk assessment (heart attack, stroke).
  • Post-COVID-19 cardiac monitoring and care.
Endocrinology – Diabetes, thyroid, metabolism:
  • Diagnosis and management of type 1 and type 2 diabetes, and prediabetes.
  • Individual treatment plans including oral medications and insulin therapy.
  • GLP-1 therapy– modern pharmacological treatment for weight management and diabetes control, including drug selection, monitoring, and safety follow-up.
  • Thyroid disorders – hypothyroidism, hyperthyroidism, autoimmune thyroid diseases (Hashimoto’s, Graves’ disease).
  • Metabolic syndrome – obesity, lipid disorders, insulin resistance.
Gastroenterology – Digestive health:
  • Abdominal pain, nausea, heartburn, gastroesophageal reflux (GERD).
  • Stomach and intestinal conditions: gastritis, irritable bowel syndrome (IBS), indigestion.
  • Management of chronic digestive disorders and interpretation of tests (endoscopy, ultrasound, labs).
General internal medicine and preventive care:
  • Respiratory infections – cough, colds, bronchitis.
  • Lab test analysis, therapy adjustments, medication management.
  • Adult vaccinations – planning, contraindications assessment.
  • Cancer prevention – screening strategies and risk assessment.
  • Holistic approach – symptom relief, complication prevention, and quality of life improvement.
Dr Biriukova combines internal medicine with specialist insight, offering clear explanations, personalised treatment plans, and comprehensive care tailored to each patient.
Camera Book a video appointment
€60
5.0 (838)
Doctor

Alina Tsurkan

Family medicine 13 years exp.

Dr. Alina Tsurkan is a licensed family medicine physician based in Portugal, offering online consultations for adults and children. She provides professional primary care, with a focus on prevention, accurate diagnosis, and long-term management of acute and chronic conditions.

Dr. Tsurkan supports patients with a wide range of health issues, including:

  • Respiratory infections: cold, flu, bronchitis, pneumonia, and lingering coughs.
  • ENT conditions: sinusitis, tonsillitis, otitis (ear infections), sore throat, allergic rhinitis.
  • Eye conditions: allergic or infectious conjunctivitis, red eyes, irritation.
  • Digestive issues: acid reflux (GERD), gastritis, irritable bowel syndrome (IBS), constipation, bloating, nausea.
  • Urinary and reproductive health: urinary tract infections (UTIs), cystitis, prevention of recurrent infections.
  • Chronic diseases: hypertension, elevated cholesterol, weight management.
  • Neurological complaints: headaches, migraines, sleep disturbances, fatigue, general weakness.
  • Children’s health: fever, infections, digestive issues, follow-ups, vaccination guidance.

She also provides:

  • IMT medical certificates for driving licence exchange in Portugal.
  • Personalised preventive care and wellness consultations.
  • Interpretation of test results and medical reports.
  • Follow-up care and medication review.
  • Support in managing multiple coexisting conditions.
  • Remote prescription management and medical documentation.

Dr. Tsurkan’s approach is evidence-based and holistic. She works closely with each patient to develop an individualised care plan that addresses both symptoms and root causes. Her goal is to empower patients to take control of their health and maintain well-being through lifestyle adjustments, routine check-ups, and early intervention.

Camera Book a video appointment
€55

Frequently Asked Questions

Is a prescription required for BRONCHIPRET FILM-COATED TABLETS?
BRONCHIPRET FILM-COATED TABLETS does not require a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in BRONCHIPRET FILM-COATED TABLETS?
The active ingredient in BRONCHIPRET FILM-COATED TABLETS is combinations. This information helps identify medicines with the same composition but different brand names.
Who manufactures BRONCHIPRET FILM-COATED TABLETS?
BRONCHIPRET FILM-COATED TABLETS is manufactured by Bionorica Se. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of BRONCHIPRET FILM-COATED TABLETS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether BRONCHIPRET FILM-COATED TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to BRONCHIPRET FILM-COATED TABLETS?
Other medicines with the same active substance (combinations) include BRONCHICLEAR ORAL SOLUTION, INISTON MUCOSITY AND CONGESTION 20 mg/ml + 6 mg/ml SYRUP, RESPIDINA EXPECTORANT JUNIOR 6 mg/mL + 20 mg/mL ORAL SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media